Skip to main content

Together we are beating cancer

Donate now

Institute

Showing 12 out of 46 results
  • For Researchers
  • Science & Technology

Embracing a full spectrum of researchers

For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research For drug discovery scientist Sebastian Greenhough, a late diagnosis of autism made sense of several things – but something it certainly didn’t do was stand in the way of his research

by Cancer Research UK | Analysis | 24 February 2022

24 February 2022

This entry is part 5 of 8 in the series Diversity in research
Vivian Li, group leader of the stem cell and cancer biology lab at the Francis Crick Institute

Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments. Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments.

by Phil Prime | In depth | 11 February 2022

11 February 2022

  • For Researchers
  • Science & Technology

Seven Centres to form new Cancer Research UK network

From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK. From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK.

by Cancer Research UK | In depth | 24 January 2022

24 January 2022

Breast cancer screening

Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding. Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding.

by Lilly Matson | Analysis | 10 January 2022

10 January 2022

Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers... Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers...

by Phil Prime | In depth | 13 December 2021

13 December 2021

The role of the nervous system in cancer progression remains largely unexplored. Now, our researchers at the Francis Crick Institute and Cancer Research UK Edinburgh Centre are leaning into the unknown to find out how cancer uses nerve cells and networks to survive and grow. The role of the nervous system in cancer progression remains largely unexplored. Now, our researchers at the Francis Crick Institute and Cancer Research UK Edinburgh Centre are leaning into the unknown to find out how cancer uses nerve cells and networks to survive and grow.

by Joanna Lewin | In depth | 1 December 2021

1 December 2021

We speak with the industrialist, investor and Cancer Research UK supporter about his substantial donation to support our early career researchers… and why he changed his mind about cancer research. We speak with the industrialist, investor and Cancer Research UK supporter about his substantial donation to support our early career researchers… and why he changed his mind about cancer research.

by Joanna Lewin | Interview | 19 November 2021

19 November 2021

As the roof goes on our brand new Cancer Research UK Manchester Institute following a devastating fire in 2017, we hear from one of the PhD students who lived through it. As the roof goes on our brand new Cancer Research UK Manchester Institute following a devastating fire in 2017, we hear from one of the PhD students who lived through it.

by Emily Armstrong | In depth | 1 November 2021

1 November 2021

prostate cancer biopsy
  • Health & Medicine
  • Science & Technology

Targeted prostate cancer screening: Are we there yet?

Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet? Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet?

by Katie Roberts | Analysis | 20 October 2021

20 October 2021

We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub… We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub…

by Phil Prime | Interview | 15 October 2021

15 October 2021